1st Circ. Revives Fraud Claims In Lexapro, Celexa MDL
The First Circuit on Wednesday gave a mother and a health and benefit fund another shot at bringing fraud claims in lengthy multidistrict litigation alleging Forest Laboratories Inc. illegally marketed the antidepressants...To view the full article, register now.
Already a subscriber? Click here to view full article